Imke Metz

Robert Koch Str, 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort Study.

Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 11, 2026

Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT.

Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT.

Journal: Frontiers in immunology

Published: April 24, 2026

Higher disease reactivation risk in women after fingolimod withdrawal.

Higher disease reactivation risk in women after fingolimod withdrawal.

Journal: Acta neuropathologica communications

Published: March 17, 2026

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

Journal: Journal of neurology

Published: January 15, 2026

Histopathologically confirmed radiation necrosis: Risk factors and clinical outcomes in patients with primary brain tumors.

Histopathologically confirmed radiation necrosis: Risk factors and clinical outcomes in patients with primary brain tumors.

Journal: Neuro-oncology practice

Published: August 15, 2025

Impaired remyelination in late-onset multiple sclerosis.

Impaired remyelination in late-onset multiple sclerosis.

Journal: Acta neuropathologica

Published: January 17, 2025

Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.

Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 11, 2024

BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis.

BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: November 04, 2023

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids.

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids.

Journal: Free neuropathology

Published: August 01, 2023

Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.

Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.

Journal: Neurology

Published: January 27, 2023

Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.

Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 27, 2022

Long-term clinical, imaging and cognitive outcomes association with MS immunopathology.

Long-term clinical, imaging and cognitive outcomes association with MS immunopathology.

Journal: Annals of clinical and translational neurology

Published: December 03, 2022

Showing 1-12 of 76

Last Updated: 09/26/2026